Lilly
Executive Summary
Lilly Senior VP-Pharmaceutical Products John Lechleiter, PhD, is promoted to exec VP-pharmaceutical products & corporate development Jan. 24. He assumes Daniels' corporate strategy duties, including oversight of outside alliances. Daniels' role in government relations, policy, external communications and community relations will be handled, on an interim basis, by Lilly Senior VP & General Counsel Rebecca Kendall. Senior VP-Human Resources & Manufacturing Pedro Granadillo will assume Daniels' responsibilities related to internal communications, also on a temporary basis
You may also be interested in...
Lilly Reloads For Medicare: Steelman Will Head Corporate Affairs
Lilly is steeling for a major role in the Medicare legislative debate by bringing Steelman Health Strategies President Deborah Steelman into the company as VP-corporate affairs.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011